Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway
Brain Research · 2027-02 · 1896 · 150645
DOI: 10.1016/j.brainres.2026.150645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2027-02. Verfasst von Surabhi Sinha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study explored the potential of peroxisome proliferator-activated receptor (α/γ) (PPAR modulators) for seizure control and the consequences of status epilepticus (SE) due to their anti-inflammatory and neuro-modulatory properties. METHOD: A lithium-pilocarpine-induced status epilepticus (SE) model in Wistar rats determined the optimal dose of PPAR modulators (fenofibrate, pemafibrate, and saroglitazar) for seizure suppression. Based on seizure parameters, an efficacy study examined PPAR modulators alone and in combination with ASMs (valproate and perampanel). Evaluations of disease-modifying effects included neurobehavioral tests, electron microscopy for neurodegeneration, immunohistochemistry (NeuN for neuronal viability and GFAP for astrocytosis), Western blotting for PPARα, HMGCS2, NLRP3, and mTOR, and ELISA for antioxidant capacity and neuroinflammatory biomarkers. RESULTS: The optimal doses of fenofibrate, pemafibrate, and saroglitazar were 200, 1.5, and 3 mg/kg, respectively. Compared with the SE-control group, drug-treated groups had higher latency (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Electronic address: scsarangi@aiims.gov.in.
- Department of Computer Science, KIET Group of Institutions, Ghaziabad, UP, India.
- Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Department of Anatomy, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Zitieren
APA
Sinha, S., Sarangi, S. C., Sharma, D., Pattnaik, S. S., Dash, Y., Nambirajan, A., Nag, T. C., Singh, S., & Tripathi, M. (2027). Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway. Brain Research, 1896, 150645. https://doi.org/10.1016/j.brainres.2026.150645
Vancouver
Sinha S, Sarangi SC, Sharma D, Pattnaik SS, Dash Y, Nambirajan A, et al. Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway. Brain Research. 2027;1896:150645. doi:10.1016/j.brainres.2026.150645
BibTeX
@article{Sinha2027,
author = {Sinha, Surabhi and Sarangi, Sudhir Chandra and Sharma, Deeksha and Pattnaik, Soumya Sucharita and Dash, Yajnaseni and Nambirajan, Aruna and Nag, Tapas Chandra and Singh, Surender and Tripathi, Manjari},
title = {Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway},
journal = {Brain Research},
year = {2027},
volume = {1896},
pages = {150645},
doi = {10.1016/j.brainres.2026.150645}
}
EUVIMED